| |
September 2022 Clinical Update: Focusing on Treatment with GIAnomics™ Oncology Germline Panel
| |
The GIAnomics™ Oncology Germline Panel (formerly the GIAnomics™ Comprehensive Hereditary Cancer Panel) provides a thorough analysis of 52 genes associated with the treatment of and predisposition to breast, ovarian, uterine, bladder, colorectal, pancreatic, prostate, melanoma, gastric and other germline cancers. In the past, germline genetic testing was only used for familial risk; now, however, based on extensive research, coupled with the FDA-approval of targeted therapies for specific pathogenic variants, germline genetic testing has become vital for treating oncology patients, driving precision, and individualizing effective treatment options.
Genetics Institute of America’s GIAnomics™ Oncology Panels are performed in our CAP-accredited and CLIA-certified high-complexity molecular diagnostics laboratory by PhD clinical scientists. GIA is committed to exceeding standards and ensuring that the panels we offer support your medical needs and your patient’s health and safety. | |
| |
Have you Seen This?:
Racial Disparity in Hereditary Cancer and Germline Genetic Testing There remains a gap in knowledge regarding the prevalence, penetrance, and manifestations of common hereditary cancer syndromes in the African-American population due to significant disparities in access and uptake of genetic testing. Read more | | | |
It's All in the Genes:
Multi-gene Panels Increase Variant Yield and Treatment Options in Ovarian Cancer Patients Without effective early detection methods and lack of specific symptoms, ovarian cancer (OC) is often left undiagnosed until late in disease progression and risk of mortality is high. Read more | | | |
Changing Corporate Culture:
Hustle to End Hunger To take another needed step towards achieving the goal of ending hunger, Genetics Institute of America will be the presenting sponsor at the CROS Ministries Hustle to End Hunger 5K on October 1st to support CROS Ministries community services. Read more | | | |
| |
| |
Enroll your Practice in GH-101! | |
Genetics Institute of America is actively recruiting practices to join our study, GH-101! The objective of this study is to take an integrative approach to the fields of pharmacogenomics, cancer genomics, mRNA microarrays and nutrigenomics by identifying DNA and RNA variants in persons with chronic disease. We are looking for Physicians and Physician Groups that currently treat patients with a chronic disease including: cancer, cardiac conditions, diabetes, kidney disease, PTSD. Getting your practice involved is easy and not only gets patients the individualized health information they need but allows your practice to be on the cutting edge of genetic research. | |
| |
| |
Thank you for the trust and confidence you have placed in our team here at the Genetics Institute of America. This monthly newsletter is our primary method of communicating to you important information about our testing and assays, general information about the Genetics Institute, as well as information impacting patient care and safety. If you would like to have another person in your practice receive these updates, please forward this to them so that they can subscribe.
 Ana Perez-Miranda, PhD, MDxT (AAB), MB (ASCP) Laboratory Manager and Molecular Diagnostics Supervisor Genetics Institute of America | | | |
| |
| |
| |
GIA Lab News is an educational service of Genetics Institute of America.
Genetics Institute of America is a national laboratory dedicated to heightening the awareness of early intervention and genetic screening to promote the longevity and quality of life outcomes. Our determination and research allow us to provide next generation DNA sequencing to deliver customized testing for identified genetic related cancers and other diseases. | |
| |
| |
4733 W. Atlantic Ave, Suite C16 Delray Beach, FL 33445 Phone: (833) 4GENLAB or (833) 443-6522 HIPAA Fax: (561) 354-5369
| |
You are receiving this email because you opted into receiving communications from Genetics Institute of America online or verbally on the phone, and/or maintain a professional relationship with our laboratory. From time to time, we’ll send newsletters, blog articles, and other educational clinical updates to our subscribers. We hope you find them useful. If not, you can unsubscribe from our list here.
Who do you know that needs to know? Forward this email Did someone forward this to you? Subscribe
Want to change how you receive these emails?
You can Unsubscribe or Update your preferences.
© 2022 Genetics Institute of America. All Rights Reserved.
| |
| |
.png)
.png)
